enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. J&J buys Intra-Cellular in $14.6 billion deal, delving ... - AOL

    www.aol.com/j-j-buys-intra-cellular-153031777.html

    FILE - The Johnson & Johnson headquarters in New Brunswick, New Jersey, on Feb. 8, 2024. ... The drug brought in $175 million in last year’s third quarter as total prescriptions increased 38%.

  3. List of Johnson & Johnson products and services - Wikipedia

    en.wikipedia.org/wiki/List_of_Johnson_&_Johnson...

    Heart and Cardiac Abiomed [2]; Cardiac Arrhythmia Diagnosis & Treatment Products (Biosense Webster) Carto 3 System [3]; Thermocool Smarttouch SF Catheter [4]; Carto Vizigo Bi-Directional Guiding Sheath [5]

  4. America’s Most Admired Lawbreaker - The Huffington Post

    highline.huffingtonpost.com/miracleindustry/...

    By Steven Brill Letter From the Editors Backstage at Johnson & Johnson. On May 20, about 100 stock analysts gathered in the ballroom of the Hyatt Regency Hotel in New Brunswick, New Jersey, to hear good news from top executives at Johnson & Johnson: The company had 10 new drugs in the pipeline that might achieve more than a billion dollars in annual sales.

  5. Johnson & Johnson - Wikipedia

    en.wikipedia.org/wiki/Johnson_&_Johnson

    Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings. In 2023, the company split-off its consumer healthcare business sector into a new publicly traded company, Kenvue .

  6. Johnson And Johnson Continues To Focus On Medical Innovation

    www.aol.com/johnson-johnson-continues-focus...

    As for Johnson & Johnson’s best-selling drugs, psoriasis treatment Stelara recorded growth of 3.1% to $2.89 billion, surpassing FactSet consensus of $2.85 billion, while cancer treatment ...

  7. Johnson & Johnson Pharmaceutical Research and Development

    en.wikipedia.org/wiki/Johnson_&_Johnson...

    J&JPRD was created in 2001 through the merging of various research organizations including McNeil Pharmaceuticals, Janssen Research Foundation, Three Dimensional Pharmaceuticals, and the R. W. Johnson Pharmaceutical Research Institute.

  8. Breakthrough antidepressants with fewer side effects could ...

    www.aol.com/finance/breakthrough-antidepressants...

    The FDA approved Johnson & Johnson’s drug for treatment-resistant depression in 2019. Esketamine is derived from a pediatric anesthetic called ketamine. Through research pioneered at Yale ...

  9. Janssen Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Janssen_Pharmaceuticals

    In 2003 two new research buildings were constructed, the Discovery Research Center (DRC), and the Drug Safety Evaluation Center (DSEC). On 27 October 2004, the Paul Janssen Research Center, for discovery research, was inaugurated. In 2011, Johnson & Johnson subsidiary Centocor became Janssen Biotech, part of Janssen Pharmaceuticals. [1]